Skip to main content

Jimini Health raises $17M to expand AI behavioral health platform

The funds will be used to expand access to its AI therapist assistant Sage that provides 24/7 clinically supervised mental health support to patients between therapy sessions.
By Jessica Hagen , Executive Editor
Person who looks upset sitting with a therapist

Photo: skynesher/Getty Images

Jimini Health, an AI-enabled clinical health platform for behavioral health providers, announced it secured $17 million in seed funding, bringing its total raise to more than $25 million.

M13, Town Hall Ventures, LionBird, Zetta Venture Partners and OneMind participated in the round.

WHAT IT DOES

The company's offering, Sage, is a clinically supervised AI therapist assistant available through a patient-facing platform. The behavioral health assistant handles patient interactions, and conversations are visible to clinical teams.

Its platform provides support 24/7 in between therapy sessions and includes exercises and guidance for individuals.

"Jimini Health will invest the new funds primarily in technology and AI to support more care settings and to expand to additional national behavioral health provider organizations," Luis Voloch, cofounder and CEO of Jimini Health, told MobiHealthNews.

MARKET SNAPSHOT

Jimini Health launched in 2024 with $8 million in pre-seed funding from LionBird, Zetta Venture Partners, Arkitekt Ventures, SCB, PsyMed, BoxGroup and others.

Other companies working in the digital mental healthcare space include New York-based Spring Health, which offers AI-enabled digital mental healthcare and navigation services.

In 2024, Spring Health scored $100 million in a Series E funding round, raising its valuation to $3.3 billion. The company secured $71 million in April 2023, two years after raising $190 million in Series C funding.

San Francisco-based telemental health company Brightside Health provides care for individuals suffering from anxiety, mild to severe clinical depression and other mood disorders through its Crisis Care psychiatry platform.

Brightside raised $33 million in Series C funding in 2024, bringing its total raise to $100 million. It secured $50 million in Series B funding in 2022 and $24 million in Series A funding the year before.